Fertility and Pregnancy
A study found that young men diagnosed with cancer were 4 to 5 times more likely to take steps to preserve fertility than young women diagnosed with cancer.
Research suggests that young women who get fertility counseling before cancer treatment have fewer regrets and better overall quality of life after treatment compared to women who don't get fertility counseling.
Women diagnosed with early-stage breast cancer who were treated with Trelstar in addition to chemotherapy might find it easier to get pregnant after chemotherapy ends, but the results weren't definitive.
Women with a BRCA1 or BRCA2 mutation who become pregnant after being treated for breast cancer don't have a higher risk of recurrence and their babies are healthy.
A study suggests that women who get pregnant after being diagnosed with breast cancer have the same recurrence risk as women who don't get pregnant after being diagnosed.
Infertility problems may be linked to lower breast cancer risk.
Most doctors advise women to wait two years after breast cancer treatment before becoming pregnant. New research suggests that women might not have to wait that long.
Five-year results found women diagnosed with early-stage, hormone-receptor-negative breast cancer who were treated with Zoladex in addition to chemotherapy before surgery were much less likely to be infertile after chemotherapy ended.
A study supports other research that suggests chemotherapy during pregnancy doesn't have harmful effects on the baby.
Research shows that premenopausal women diagnosed with hormone-receptor-negative, early-stage breast cancer who were treated with Zoladex and chemotherapy were much less likely to be infertile.
Freezing embryos created from eggs extracted before treatment allowed women diagnosed with early-stage breast cancer to become pregnant at rates similar to women not diagnosed with breast cancer who underwent in vitro fertilization.
A large Dutch study strongly suggests that in vitro fertilization (IVF), a type of fertility treatment, doesn't appear to increase breast cancer risk, even years after the fertility treatment.
A study found that women with a BRCA1 mutation had levels of a hormone that indicates how many eggs are left in the ovaries that were 25% lower than women who didn't have the mutation.
Most women can carry a baby to full term if diagnosed when pregnant; some treatments can be given during pregnancy while others should wait until after delivery.
Women being treated for infertility do not have a higher risk of breast cancer.
A new analysis suggests that pregnancy doesn't negatively affect the future survival of women who've been diagnosed with breast cancer.
A study has found that the likelihood that a woman who's been diagnosed with cancer will get fertility counseling before cancer treatment starts depends on her race, educational background, and economic situation.
A study suggests that women younger than 50 who use fertility drugs to successfully conceive a child may see their risk of breast cancer go up. But this higher risk is about the same as the average woman's risk.
A meta-analysis suggests that premenopausal women diagnosed with early-stage breast cancer who are treated with gonadotropin-releasing hormone analog during chemotherapy are more likely to have their periods return after treatment ends and may be more likely to have children after breast cancer treatment.
Women with a history of infertility had denser breasts than women who didn't have fertility problems, and infertile women who had controlled ovarian stimulation had denser breasts than women who didn't have the treatment.
Women who have been treated for breast cancer are less likely than the average woman to get pregnant and have a higher risk of certain complications, such as preterm labor, but most deliver healthy babies and childbirth has no effect on their long-term survival.
Younger women diagnosed with hormone-receptor-positive breast cancer may skip or delay taking hormonal therapy medicine after surgery because they’re concerned about having children.
Women with a mutation in the BRCA1 gene likely have fewer eggs in their ovaries than the average woman, which may shorten their window of opportunity to have children.
Medicines commonly used to stimulate the ovaries to release eggs during fertility treatment don’t seem to increase the risk of developing breast cancer.